DISEASE INDICATIONS: Rheumatoid Arthritis

MANUFACTURER: Galapagos

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Pharmaceuticals and Medical Devices Agency (PMDA)

Jyseleca (filgotinib) is a drug prescribed for the treatment of moderate to severe rheumatoid arthritis in adults.